{"nct_id":"NCT00726323","title":"A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)","status":"COMPLETED","status_verified_date":"2017-09","start_date":"2006-06-30","start_date_type":"ACTUAL","primary_completion_date":"2010-08-18","primary_completion_date_type":"ACTUAL","completion_date":"2010-08-18","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}